158 related articles for article (PubMed ID: 18256784)
1. Clonality investigation of morphologically dysplastic hematopoietic cells in myelodysplastic syndrome marrows.
Li X; Wu L; Ying S; Chang C; Pu Q
Int J Hematol; 2008 Mar; 87(2):176-183. PubMed ID: 18256784
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome.
Kuriyama K; Tomonaga M; Matsuo T; Ginnai I; Ichimaru M
Br J Haematol; 1986 Aug; 63(4):665-9. PubMed ID: 3460627
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes.
Hast R; Eriksson M; Widell S; Arvidsson I; Bemell P
Leuk Res; 1999 Jun; 23(6):579-84. PubMed ID: 10374851
[TBL] [Abstract][Full Text] [Related]
4. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
5. Clonal origin and evolution of myelodysplastic syndrome analyzed by dysplastic morphology and fluorescence in situ hybridization.
Fu CM; Chen ZX; Liu DD; Zhang J; Pan JL; Liang JY
Int J Hematol; 2015 Jan; 101(1):58-66. PubMed ID: 25430081
[TBL] [Abstract][Full Text] [Related]
6. Pseudo-Pelger-Huët anomaly induced by medications: a clinicopathologic study in comparison with myelodysplastic syndrome-related pseudo-Pelger-Huët anomaly.
Wang E; Boswell E; Siddiqi I; Lu CM; Sebastian S; Rehder C; Huang Q
Am J Clin Pathol; 2011 Feb; 135(2):291-303. PubMed ID: 21228370
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic clonality analysis of megakaryocytes in myelodysplastic syndrome by dual-color fluorescence in situ hybridization and confocal laser scanning microscopy.
van Lom K; Houtsmuller AB; van Putten WL; Slater RM; Löwenberg B
Genes Chromosomes Cancer; 1999 Aug; 25(4):332-8. PubMed ID: 10398426
[TBL] [Abstract][Full Text] [Related]
8. [Myelodysplastic syndrome in a patient with familial Pelger-Huet anomaly].
Hiraga H; Yabe H; Nagai K; Nakayama S
Rinsho Ketsueki; 1991 Nov; 32(11):1453-7. PubMed ID: 1758052
[TBL] [Abstract][Full Text] [Related]
9. [Study of the clonal origin and development of MDS by FISH analysis of dysplasia cells in bone marrow of patients with MDS].
Fu CM; Chen ZX; Liu DD; Zhang J; Pan JL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):650-6. PubMed ID: 23815916
[TBL] [Abstract][Full Text] [Related]
10. [Nuclear abnormalities in Pelger-Huet anomaly; progress in blood cell morphology].
Tomonaga M
Rinsho Byori; 2005 Jan; 53(1):54-60. PubMed ID: 15724491
[TBL] [Abstract][Full Text] [Related]
11. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
12. Genetic and Clinical Studies of Patients With Increased Multinucleated Megakaryocytes in Bone Marrow as an Isolated Finding: A Diagnostic Pitfall for Myelodysplastic Syndrome.
Zheng G; He R; Reichard KK; Peterson JF; Olteanu H; Oliveira JL; Rangan A; Chen D; Shi M
Am J Surg Pathol; 2021 Nov; 45(11):1534-1540. PubMed ID: 33999554
[TBL] [Abstract][Full Text] [Related]
13. Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Huët anomaly and small vacuolated granulocytes.
Laï JL; Zandecki M; Fenaux P; Le Baron F; Bauters F; Cosson A; Deminatti M
Cancer Genet Cytogenet; 1990 Jun; 46(2):173-83. PubMed ID: 2340488
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of dysplasia characteristics in typing of myelodysplastic syndrome].
Li J; Zhang M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):657-61. PubMed ID: 23815917
[TBL] [Abstract][Full Text] [Related]
15. Inter-observer variance and the need for standardization in the morphological classification of myelodysplastic syndrome.
Sasada K; Yamamoto N; Masuda H; Tanaka Y; Ishihara A; Takamatsu Y; Yatomi Y; Katsuda W; Sato I; Matsui H;
Leuk Res; 2018 Jun; 69():54-59. PubMed ID: 29656215
[TBL] [Abstract][Full Text] [Related]
16. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears.
Bigoni R; Cuneo A; Milani R; Cavazzini F; Bardi A; Roberti MG; Agostini P; della Porta M; Specchia G; Rigolin GM; Castoldi G
Haematologica; 2001 Apr; 86(4):375-81. PubMed ID: 11325642
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Abnormal Clones in Myelodysplastic Syndrome Marrow Originate from Cells at a Pluripotent Stem Level and Maintain Their Early Differentiation Potency.
Qi H; Qingxia Z; Xiao L; Lingyun W; Feng X; Zheng Z; Chunkang C
Cancer Invest; 2015; 33(8):369-77. PubMed ID: 26135215
[TBL] [Abstract][Full Text] [Related]
18. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
Mangi MH; Mufti GJ
Blood; 1992 Jan; 79(1):198-205. PubMed ID: 1370203
[TBL] [Abstract][Full Text] [Related]
19. Normal bone marrow function over 6 years in a patient with dysplastic hematopoiesis and a complex karyotype.
Valent P; Fonatsch C; Stindl R; Schwarzinger I; Haas OA; Sperr WR; Geissler K; Lechner K
Leuk Res; 2004 Jun; 28(6):651-5. PubMed ID: 15120944
[TBL] [Abstract][Full Text] [Related]
20. Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastic syndromes and a del(5q), including the 5q- syndrome.
Godon C; Talmant P; Garand R; Accart F; Bataille R; Avet-Loiseau H
Genes Chromosomes Cancer; 2000 Dec; 29(4):350-2. PubMed ID: 11066080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
